Jul 30, 2025 | Uncategorized
The U.S. Food and Drug Administration is moving to restrict 7-hydroxymitragynine (7-OH), a derivative of the kratom plant that is commonly sold online and in vape stores. Citing concerns that 7-OH has opioid-like effects and could be similarly addictive, Health...
Jul 24, 2025 | False Claims Act, federal investigations, Fraud Investigations
In yet another False Claims Act (FCA) settlement involving avoidance of customs duties, on July 23, 2025, the Department of Justice (DOJ) announced that New Hampshire-based Global Plastics and Marco Polo International — both subsidiaries of MGI International...
Jul 22, 2025 | False Claims Act, federal investigations, Fraud Investigations
On July 15, the United States Attorney’s Office for the District of South Carolina announced that it had intervened in a case brought under the False Claims Act (FCA)’s qui tam (whistleblower) provisions. The lawsuit was filed against Global Office...
Jul 17, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid
On July 17, 2025, the Department of Justice (DOJ) and the States of Colorado, Georgia, and South Carolina announced that the former CEO and owner of a now-defunct laboratory agreed to a consent judgment of over $27.5 million under the False Claims Act (FCA),...
Jul 17, 2025 | False Claims Act, federal investigations, Government Investigations, Health Care, Health Care Fraud
The False Claims Act (FCA) is the government’s most powerful civil tool to investigate and pursue claims against businesses and individuals who submit false or fraudulent claims to the government. Every year, the Department of Justice (DOJ) obtains billions of dollars...
